the TauRx hydromethylthionine (HMTM/LMTM) tau-inhibitor derivative that reached the Phase 3 LUCIDITY Alzheimers trial and a July 2024 UK MHRA application
Involving others in assessment adds valuable perspective
Safranin O Staining Pellets were fixed overnight at 4C in 10% buffered formalin (Fisher Chemical, Hampton, NH, United States), dehydrated in gradient ethanol, cleared in xylene, and then embedded in paraffin
Pricing Pricing is significantly higher than MileHighCompounds and Orbitrex Peptides, reflecting additional investment in verification, testing, and documentation
This genetic information could theoretically guide glutathione supplementation protocols, though clinical applications of this approach remain under development